Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dyne Therapeutics granted inducement equity awards to 16 newly hired employees under Nasdaq Listing Rule 5635(c)(4). The awards comprise non-statutory stock options on 290,100 shares priced at the October 20, 2026 closing price, plus RSUs covering 92,300 shares, both vesting over four years.
Key figures
- New hires
- 16
- Rsu shares
- 92300
- Option shares
- 290100
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.